Mediterranean Journal of Infection, Microbes and Antimicrobials

Aims & Scope

Mediterranean Journal of Infection, Microbes and Antimicrobials (MJIMA) is the official journal of the Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (TÜRKİYE-EKMUD).

MJIMA is an independent international journal based on peer-review principle.

It is an online open-access journal, launched in 2011.

The publisher of the journal is Galenos Publishing House (2011-15 Bilimsel Publishing).

A double-blind peer-reviewed system is used to select manuscripts.

The official languages of the journal are Turkish and English.

As of 2017, papers submitted in Turkish and accepted after peer review, will be published in English after translation.

Translation process will be organized by MJIMA.

Authors will not be charged any fee for translation.

After approval of the translation by the author the paper will be published.

Manuscripts submitted in English will be published only in English.

The goal of the Journal is to present and improve collective scientific knowledge and the scientific background regarding infectious diseases, clinical microbiology, vaccinology, infection control and hospital epidemiology via experimental and clinical studies, reviews, case reports, short communications, letters to the editor, editorials and clinical images.

To undertake a novel effort in the international representation and attribution of published articles are the other aims of the journal.

Research papers are especially supported.

The target readers of the MJIMA include, infectious diseases and/or clinical microbiology specialists and residents.

However, the articles published may also be related to infection control practitioners, epidemiologists, intensive care medicine, anesthesiology and reanimation, oncology, hematology, neurology, surgery, public health and internal medicine specialists and residents as well as all other physicians working related to the field of infectious diseases and clinical microbiology.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Immunology and Microbiology and Medicine, ensuring accessibility and quality in research dissemination.

This journal does not charge a mandatory Article Processing Charge (APC). However, optional open access publication may incur fees based on the publisher’s policies.

Explore journals without APCs for alternative publishing options.